HISTORICAL FACTS: Optinose | History Defined

Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue To Soar?

Organogenesis (ORGO) shares rallied 5.3% in the last trading session to close at $5.19. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.4% gain over the past four weeks.

Benzinga · Jul 13, 2022

Looking Into OptiNose's Return On Capital Employed

Benzinga Pro data, OptiNose (NASDAQ:OPTN) reported Q1 sales of $14.76 million. Earnings fell to a loss of $25.33 million, resulting in a 62.14% decrease from last quarter.

Benzinga · Jun 16, 2022

OptiNose: Q1 Earnings Insights

  OptiNose (NASDAQ:OPTN) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022